Ads
related to: stage 2 breast cancer- Overall Survival Results
See Updated Overall Survival Data
For This Treatment Option
- Dosing & Administration
Read More About Dosing
And How To Prescribe
- Financial Resources
Learn About The Available Access
Programs For Your Patients
- Official Video Library
See A Medical Expert Discuss
Overall Survival Data For mBC
- Patient Support
View The The Service Request Form
To Gain Access To Support Programs
- Safety Profile
View The Full Safety Profile And
See Side Effects For This Option
- Overall Survival Results
Search results
Mom, 33, worried for years her mole was cancer. Doctors dismissed it. Her 2-year-old saved her
Today· 3 days agoIn 2010, Amanda Eilian, then 33, was heading out with her two daughters when her older daughter made...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
AOL· 23 hours agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main goal of overall survival. In the overall study population, there was a higher number of deaths ...
Exact Sciences (EXAS) to Showcase Favorable Research Outcome
Zacks via Yahoo Finance· 3 days agoExact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies...
IceCure Medical Maintains Positive Momentum and Reports Sales Growth for Cryoablation System in...
WJTV Jackson· 3 days agoDuring the quarter, the Company completed its landmark ICE3 trial and recently achieved several objectives, including: publishing and submitting the full data set of its ICE3 trial results to ...
Kate Middleton to Miss Trooping the Colour Event Amid Cancer Treatment
E! News via Yahoo News· 1 day agoCancer The Duchess of York's rep said in a statement on Jan. 21 that Sarah was recently diagnosed...
Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 day agoR&D expense increased 27% to $2.52 billion in the quarter due to higher costs for late-stage as well...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 15 hours agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
Zacks· 3 days agoThe FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
Merck’s KEYTRUDA shows survival benefits in Phase III TNBC trial
Clinical Trials Arena via Yahoo Finance· 2 days agoKEYTRUDA is an anti-PD-1 therapy and was assessed...adjuvant). The double-blind randomised study...
Top 10 most common cancers among Blacks
Rolling Out· 2 days agoUnderstanding the most common cancers among African Americans is crucial for improving prevention, early detection, and treatment strategies.
Ad
related to: stage 2 breast cancer
